Spatiotemporally Controlled Co-delivery of Anti-vasculature Agent and Cytotoxic Drug by Octreotide-Modified Stealth Liposomes

Octreotide-Modified Polymeric Micelles as Potential Carriers for Targeted Docetaxel Delivery to Somatostatin Receptor Overexpressing Tumor Cells

(2011) Yuan Zhang et al.   PHARMACEUTICAL RESEARCH

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies

(2010) Yi-fei Zhang et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

A Novel Octreotide Modified Lipid Vesicle Improved the Anticancer Efficacy of Doxorubicin in Somatostatin Receptor 2 Positive Tumor Models

(2010) Junlin Zhang et al.   MOLECULAR PHARMACEUTICS

Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumorin vitroandin vivo

(2010) Minjie Sun et al.   NANOTECHNOLOGY

Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

(2009) Siow Ming Lee et al.   JNCI-Journal of the National Cancer Institute

Paclitaxel–octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice

(2008) Hongchang Shen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers

(2008) F. Gu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Somatostatin, cortistatin and their receptors in tumours

(2007) M. Volante et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY